Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$20.25 USD
-0.47 (-2.27%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $20.25 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Cash flow Statements
Fiscal Year End for Fresenius Medical Care AG & Co KGaA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 792.74 | 942.26 | 1,442.23 | 1,640.15 | 1,611.12 |
Depreciation/Amortization & Depletion | 1,896.16 | 1,936.90 | 1,920.97 | 2,040.03 | 1,784.34 |
Net Change from Assets/Liabilities | 607.47 | -134.93 | -115.67 | 1,411.27 | -13.94 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -451.22 | -460.68 | -302.21 | -255.92 | -506.53 |
Net Cash From Operating Activities | 2,845.15 | 2,283.55 | 2,945.33 | 4,835.53 | 2,874.99 |
Property & Equipment | -723.47 | -724.65 | -981.90 | -1,183.89 | -1,246.85 |
Acquisition/ Disposition of Subsidiaries | 148.27 | 1.08 | -451.62 | -279.15 | -2,433.46 |
Investments | -13.82 | -50.54 | 18.26 | -61.87 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -589.02 | -774.11 | -1,415.26 | -1,524.90 | -3,680.31 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 21.23 | 7.70 | -403.61 | -654.00 |
Issuance (Repayment) of Debt | -306.06 | 255.29 | -992.51 | 610.77 | 1,393.06 |
Increase (Decrease) Short-Term Debt | -981.65 | -1,433.22 | 567.89 | -2,056.92 | -1,036.28 |
Payment of Dividends & Other Distributions | -694.82 | -740.65 | -860.47 | -819.54 | -728.90 |
Other Financing Activities | -28.95 | 193.30 | 65.44 | -373.82 | 503.50 |
Net Cash from Financing Activities | -2,011.49 | -1,704.05 | -1,211.95 | -3,043.12 | -522.63 |
Effect of Exchange Rate Changes | -78.58 | -24.40 | 155.26 | -183.19 | 53.49 |
Net Change In Cash & Equivalents | 166.07 | -219.01 | 473.38 | 84.32 | -1,274.46 |
Cash at Beginning of Period | 1,378.62 | 1,561.07 | 1,279.57 | 1,151.12 | 2,403.11 |
Cash at End of Period | 1,544.69 | 1,342.06 | 1,752.95 | 1,235.44 | 1,128.65 |
Diluted Net EPS | 0.92 | 1.21 | 1.96 | 2.26 | 2.22 |
Fiscal Year End for Fresenius Medical Care AG & Co KGaA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 386.35 | 128.45 | 792.74 | 517.93 | 358.52 |
Depreciation/Amortization & Depletion | 968.63 | 556.36 | 1,896.16 | 1,443.26 | 950.83 |
Net Change from Assets/Liabilities | -330.86 | -456.90 | 607.47 | 477.84 | 120.76 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -410.57 | -89.70 | -451.22 | -360.47 | -176.17 |
Net Cash From Operating Activities | 613.54 | 138.22 | 2,845.15 | 2,078.56 | 1,253.94 |
Property & Equipment | -304.33 | -140.59 | -723.47 | -467.57 | -322.58 |
Acquisition/ Disposition of Subsidiaries | 533.30 | 44.06 | 148.27 | 4.88 | 12.06 |
Investments | 44.77 | 22.31 | -13.82 | -24.62 | -12.92 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 273.73 | -74.23 | -589.02 | -487.31 | -323.44 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | -222.02 | -7.77 | -306.06 | 190.87 | -16.23 |
Increase (Decrease) Short-Term Debt | -507.97 | -550.43 | -981.65 | -720.71 | -141.37 |
Payment of Dividends & Other Distributions | -470.48 | -61.83 | -694.82 | -612.63 | -528.43 |
Other Financing Activities | -13.23 | 305.55 | -28.95 | -68.78 | -77.84 |
Net Cash from Financing Activities | -1,213.70 | -314.48 | -2,011.49 | -1,211.25 | -763.87 |
Effect of Exchange Rate Changes | -13.17 | -4.90 | -78.58 | -52.85 | -71.20 |
Net Change In Cash & Equivalents | -339.60 | -255.39 | 166.07 | 327.14 | 95.42 |
Cash at Beginning of Period | 1,536.98 | 1,549.54 | 1,378.62 | 1,386.39 | 1,388.94 |
Cash at End of Period | 1,197.38 | 1,294.15 | 1,544.69 | 1,713.53 | 1,484.36 |
Diluted Net EPS | 0.34 | 0.13 | 0.34 | 0.16 | 0.26 |